EE743 Assessment of the Budgetary Impact of Introducing Pegcetacoplan and Ravulizumab for Treating Paroxysmal Nocturnal Hemoglobinuria (PNH) in the Kingdom of Saudi Arabia
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.1023
https://www.valueinhealthjournal.com/article/S1098-3015(24)03886-5/fulltext
Title :
EE743 Assessment of the Budgetary Impact of Introducing Pegcetacoplan and Ravulizumab for Treating Paroxysmal Nocturnal Hemoglobinuria (PNH) in the Kingdom of Saudi Arabia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)03886-5&doi=10.1016/j.jval.2024.10.1023
First page :
Section Title :
Open access? :
No
Section Order :
10518